CD4 c.928C>A ;(p.Q310K)

Variant ID: 12-6925542-C-A

NM_000616.4(CD4):c.928C>A;(p.Q310K)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


CXCL10 potentiates immune checkpoint blockade therapy in homologous recombination-deficient tumors.

Theranostics
Shi, Zhiwen Z; Shen, Jianfeng J; Qiu, Junjun J; Zhao, Qingguo Q; Hua, Keqin K; Wang, Hongyan H
Publication Date: 2021

Variant appearance in text: CD4: 928C>A; Q310K
PubMed Link: 34158843
Variant Present in the following documents:
  • thnov11p7175s3.xlsx, sheet 1
View BVdb publication page